T
Taysha Gene Therapies
Dallas, United States
Founded 2019 NASDAQ: TSHA
Gene Therapy Delivery Nanomedicine Nano-Bio Regenerative Medicine Protein Nanoparticles Drug Delivery
About
Gene therapy company developing treatments for monogenic CNS diseases
Company Details
- Type
- public
- Employees
- 150+
- Funding
- Public
Key Products
- TSHA-102
- TSHA-120
- TSHA-118